10X genomics, INC.:1279204 [23-003486]

Ended Awarded Last action

Contract number
75N92B23F90027
Awardee
Awarding agency
Obligated
$11,000

Award facts

Contract value 100% obligated
$11,000.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a BPA call to 10X Genomics, Inc. for $11,000.00 on April 13, 2022, covering two 12-month Chromium assurance plan maintenance agreements for instruments S/N 60642 and S/N 61748 with performance periods from August 1, 2023 through July 31, 2024. Place of performance is Pleasanton, California. The call is priced firm fixed and carries no set-aside. Ultimate completion date is July 31, 2024.

Quick answers

Who was awarded contract 75N92B23F90027?

75N92B23F90027 was awarded to 10X Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on April 13, 2022.

How much is contract 75N92B23F90027 worth?

The government has obligated $11,000 on 75N92B23F90027.

Is contract 75N92B23F90027 an order under another contract?

Yes. 75N92B23F90027 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92B23F90027 competed?

The extent of competition for 75N92B23F90027 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award